کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
9016318 | 1128089 | 2005 | 6 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
HDRSHARSAnxiety - اضطرابDepression - افسردگیAlcohol - الکلDetoxification - سم زداییGlobal assessment scale - مقیاس ارزیابی جهانیHamilton anxiety rating scale - مقیاس درجه اضطراب همیلتونHamilton Depression Rating Scale - مقیاس رتبه بندی افسردگی همیلتونMirtazapine - میرتازاپینVenlafaxine - ونلافاکسینGas - گاز
موضوعات مرتبط
علوم زیستی و بیوفناوری
علم عصب شناسی
روانپزشکی بیولوژیکی
پیش نمایش صفحه اول مقاله

چکیده انگلیسی
Symptoms of anxiety and depression are common in a large proportion of alcohol-abusing/dependent individuals during alcohol detoxification. The aim of this study was to examine the impact of a combined psychotherapeutic-psychopharmacological (either with mirtazapine or venlafaxine) treatment of these symptoms during the early withdrawal phase of alcohol compared to a group treated only with psychotherapy. A total of 60 alcohol-dependent/abusing subjects randomly assigned to three groups (psychotherapy, psychotherapy plus mirtazapine, psychotherapy plus venlafaxine) were studied. Assessment of psychopathology and global functioning throughout a 4-5-week detoxification period was done by the Hamilton Anxiety Rating Scale (HARS), the Hamilton Depression Rating Scale (HDRS), and the Global Assessment Scale (GAS). At baseline, high scores of anxiety and depression were recorded (HARS: controls: 33.1±7.8, mirtazapine: 33.2±12.6, venlafaxine: 36.6±5.4; HDRS: controls: 39.5±7.4, mirtazapine: 37.9±7.8, venlafaxine: 41.9±4.5). A marked improvement (p<0.000) was evidenced in all groups by the end of the detoxification period. However, patients on mirtazapine improved significantly more compared to the other two groups (HARS: controls: 9.6±7.6, mirtazapine: 4.3±4.4*, venlafaxine: 7.2±4.1, *p=0.011; HDRS: controls: 8.6±7.9, mirtazapine: 3.8±3.2*, venlafaxine: 8.2±3.5, *p=0.017; GAS: controls: 79.5±9.4, mirtazapine: 87.5±5.5**, venlafaxine: 83.0±8.0, **p=0.006). It is concluded that addition of mirtazapine, but not venlafaxine, to a standard psychotherapy-oriented alcohol detoxification treatment may facilitate the detoxification process by minimizing psychological discomfort. Consequently, it may prove to be a facilitator for the long-term abstinence from alcohol.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Progress in Neuro-Psychopharmacology and Biological Psychiatry - Volume 29, Issue 1, January 2005, Pages 55-60
Journal: Progress in Neuro-Psychopharmacology and Biological Psychiatry - Volume 29, Issue 1, January 2005, Pages 55-60
نویسندگان
John Liappas, Thomas Paparrigopoulos, Elias Tzavellas, Andreas Rabavilas,